Jeffrey M Rosen (J M Rosen)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Epithelial Mesenchymal Transition

Long Noncoding Rna

Quality Control

Top Venues

Cancer research

Nature cell biology

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Xueying Yuan, Xiaoxin Hao, Hilda L Chan, Na Zhao, Diego A Pedroza, Fengshuo Liu, Kang Le, Alex J Smith, Sebastian J Calderon, Nadia Lieu, Michael J Soth, Philip Jones, Xiang H F Zhang, Jeffrey M Rosen
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC. bioRxiv : the preprint server for biology (2024)
Xueying Yuan, Xiaoxin Hao, Hilda L Chan, Na Zhao, Diego A Pedroza, Fengshuo Liu, Kang Le, Alex J Smith, Sebastian J Calderon, Nadia Lieu, Michael J Soth, Philip Jones, Xiang H F Zhang, Jeffrey M Rosen
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC. bioRxiv : the preprint server for biology (2024)
Oluwatoyosi Adewunmi, Yichao Shen, Xiang H F Zhang, Jeffrey M Rosen
Targeted inhibition of lncRNA Malat1 alters the tumor immune microenvironment in preclinical syngeneic mouse models of triple negative breast cancer. Cancer immunology research (2023)
Ho Ngai, Gabriel A Barragán, Gengwen Tian, Julien C Balzeau, Chunchao Zhang, Amy N Courtney, Linjie Guo, Xin Xu, Michael S Wood, Janice M Drabek, Thorsten Demberg, Caroline M Sands, Cynthia N Chauvin-Fleurence, Erica J Di Pierro, Jeffrey M Rosen, Leonid S Metelitsa
LEF1 drives a central memory program and supports antitumor activity of natural killer T cells. Cancer immunology research (2022)
Meng Lin, Amy T Ku, Jie Dong, Fei Yue, Weiyu Jiang, Ahmed Atef Ibrahim, Fanglue Peng, Chad J Creighton, Chandandeep Nagi, Carolina Gutierrez, Jeffrey M Rosen, Xiang H F Zhang, Susan G Hilsenbeck, Xi Chen, Yi-Chieh Nancy Du, Shixia Huang, Aiping Shi, Zhimin Fan, Yi Li
STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential. Oncogene 41 (48) (2022)
Mahnaz Janghorban, Yuchen Yang, Na Zhao, Clark Hamor, Tuan M Nguyen, Xiang H F Zhang, Jeffrey M Rosen
Single-Cell Analysis Unveils the Role of the Tumor Immune Microenvironment and Notch Signaling in Dormant Minimal Residual Disease. Cancer research 82 (5) (2022)
Swarnima Singh, Nigel Lee, Diego A Pedroza, Igor L Bado, Clark Hamor, Licheng Zhang, Sergio Aguirre, Jingyuan Hu, Yichao Shen, Yitian Xu, Yang Gao, Na Zhao, Shu-Hsia Chen, Ying-Wooi Wan, Zhandong Liu, Jeffrey T Chang, Daniel Hollern, Charles M Perou, Xiang H F Zhang, Jeffrey M Rosen
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer. Cancer research 82 (12) (2022)
Na Zhao, Reid T Powell, Xueying Yuan, Goeun Bae, Kevin P Roarty, Fabio Stossi, Martina Strempfl, Michael J Toneff, Hannah L Johnson, Sendurai A Mani, Philip Jones, Clifford C Stephan, Jeffrey M Rosen
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition. Nature communications 12 (1) (2021)
Daniel J McGrail, Patrick G Pilié, Hui Dai, Truong Nguyen Anh Lam, Yulong Liang, Leonie Voorwerk, Marleen Kok, Xiang H F Zhang, Jeffrey M Rosen, Amy B Heimberger, Christine B Peterson, Eric Jonasch, Shiaw-Yih Lin
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers. Science translational medicine 13 (617) (2021)
Hin Ching Lo, Zhan Xu, Ik Sun Kim, Bradley Pingel, Sergio Aguirre, Srikanth Kodali, Jun Liu, Weijie Zhang, Aaron M Muscarella, Sarah M Hein, Alexander S Krupnick, Joel R Neilson, Silke Paust, Jeffrey M Rosen, Hai Wang, Xiang H F Zhang
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis. Nature cancer 1 (7) (2020)
Swarnima Singh, Xiang H F Zhang, Jeffrey M Rosen
TIME Is a Great Healer-Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes. Cells 10 (1) (2020)
Longyong Xu, Xia Liu, Fanglue Peng, Weijie Zhang, Liting Zheng, Yao Ding, Tianpeng Gu, Kaosheng Lv, Jin Wang, Laura Ortinau, Tianyuan Hu, Xiangguo Shi, Guojun Shi, Ge Shang, Shengyi Sun, Takao Iwawaki, Yewei Ji, Weibo Xie, Jeffrey M Rosen, Xiang H F Zhang, Dongsu Park, Stanley Adoro, Andre Catic, Wei Tong, Ling Qi, Daisuke Nakada, Xi Chen
Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and niche interactions. Nature cell biology 22 (10) (2020)
Tuan M Nguyen, Sumayya Alchalabi, Oluwatoyosi Adewunmi, Ali S Ropri, Jason I Herschkowitz, Jeffrey M Rosen
New twists on long noncoding RNAs: from mobile elements to motile cancer cells. RNA biology 17 (11) (2020)
S J Kim, S Garcia-Recio, Chad J Creighton, Charles M Perou, Jeffrey M Rosen
Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression. Oncogene 38 (31) (2019)
Ik Sun Kim, Yang Gao, Thomas Welte, Hai Wang, Jun Liu, Mahnaz Janghorban, Kuanwei Sheng, Yichi Niu, Amit Goldstein, Na Zhao, Igor Bado, Hin-Ching Lo, Michael J Toneff, Tuan Nguyen, Wen Bu, Weiyu Jiang, James Arnold, Franklin Gu, Jian He, Deborah Jebakumar, Kimberly Walker, Yi Li, Qianxing Mo, Thomas F Westbrook, Chenghang Zong, Arundhati Rao, Arun Sreekumar, Jeffrey M Rosen, Xiang H F Zhang
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nature cell biology 21 (9) (2019)
Rama Soundararajan, Jared J Fradette, Jessica M Konen, Stacy Moulder, Xiang Zhang, Don L Gibbons, Navin Varadarajan, Ignacio I Wistuba, Debasish Tripathy, Chantale Bernatchez, Lauren A Byers, Jeffrey T Chang, Alejandro Contreras, Bora Lim, Edwin Roger Parra, Emily B Roarty, Jing Wang, Fei Yang, Michelle Barton, Jeffrey M Rosen, Sandurai A Mani
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy. Cancers 11 (5) (2019)